Home > Press > BioForce Nanosciences Exceeds 2006 Goal for Shipping Nano eNabler(TM) Printers
BioForce Nanosciences,Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc.
(OTC Bulletin Board: BFNH.OB), announced that it exceeded its 2006 goal for
shipping up to 20 of its cutting-edge Nano eNabler(TM) molecular printers
to prestigious institutions across the globe. BioForce exceeded its goal by
two units by year end. These pilot placements of the Company's patented
Nano eNabler device at centers of research excellence, allow the
entrepreneurial researchers at those centers to act as "early adopters" of
BioForce's practical tools and technologies.
BioForce Nanosciences Exceeds 2006 Goal for Shipping Nano eNabler(TM) Printers
AMES, Iowa | Posted on January 26th, 2007
"With the shipment of these 22 Nano eNabler molecular printers," says
BioForce Product Manager Michael Lynch, "BioForce is now essentially
partnering with an impressive group of innovators working in the micro and
nanotechnology fields. Several groups have already expressed a desire to
seek funds to convert their placement into a purchase."
Kerry Frey, BioForce's chief operating officer, says, "BioForce
Nanosciences is positioned between two very exciting markets-nanotechnology
and the life sciences. We strongly believe our Nano eNabler system will
change how research is conducted in laboratories across the world." He
explains that the ease of use and practicality provided by the Nano eNabler
system, establish a path from laboratory to industry.
Institutions where recent placements have taken place:
* University of California, Cal-it2, Irvine, CA
* Cornell University, NanoBioTechnology Center, Ithaca, NY
* ETH Zurich, Zurich, Switzerland
* Georgia Institute of Technology, Microelectronics Research Center,
* Stanford University, James H. Clark Center, Stanford, CA
About BioForce Nanosciences
BioForce Nanosciences, Inc. is a wholly owned subsidiary of BioForce
Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH.OB). BioForce
Nanosciences is a unique company entering into commercialization with over
a decade of research and accomplishment in the field of bionanotechnology.
BioForce has demonstrated the ability to take a product from concept to
commercial sale. For more information, visit http://www.bioforcenano.com.
This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the Company's most recent filings with the
Securities and Exchange Commission. The Company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.
For more information, please click here
Copyright © PR Newswire
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Nano Labs Shareholder Update March 8th, 2014
Squeezing light into metals: University of Utah engineers control conductivity with inkjet printer March 7th, 2014
Up-Converted Radio: The way to treat radio waves in a noisy environment is to turn them into visible light March 7th, 2014
Carbodeon NanoDiamonds PTFE Coating doubles surface durability and reduces friction by up to 66 percent: New surface coating enables cost-effective CO2 and fuel reductions in machinery March 6th, 2014
Colored diamonds are a superconductor’s best friend March 6th, 2014
Take Your Best Shot! JEOL Launches SEM/TEM Image Contest March 6th, 2014
Nanopositioning Stage & Digital Controller for Imaging, Surface Metrology and Microscopy Available from PI March 6th, 2014
Elmarco Enabled Industrial Electrospinning Technology for Laboratories: Elmarco introduces NS LAB, the electrospinning research tool designed for the needs of universities and research institutes March 6th, 2014
Arrowhead Reports Fiscal 2014 First Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time February 4th, 2014
Arrowhead to Report Fiscal 2014 First Quarter Financial Results - Conference Call Scheduled for Tuesday, February 4, 2014 January 28th, 2014
Nanometrics to Announce Fourth Quarter and Full Year Financial Results on February 4, 2014 January 15th, 2014
Nanobiotix 2013 Review: Significant Corporate and Clinical Progress January 7th, 2014